SMT201300038B - Formulazione di paracetamolo iniettabile stabile epronto per l'uso - Google Patents

Formulazione di paracetamolo iniettabile stabile epronto per l'uso

Info

Publication number
SMT201300038B
SMT201300038B SM201300038T SM201300038T SMT201300038B SM T201300038 B SMT201300038 B SM T201300038B SM 201300038 T SM201300038 T SM 201300038T SM 201300038 T SM201300038 T SM 201300038T SM T201300038 B SMT201300038 B SM T201300038B
Authority
SM
San Marino
Prior art keywords
ready
stable injectable
paracetamol formulation
injectable paracetamol
formulation
Prior art date
Application number
SM201300038T
Other languages
English (en)
Inventor
Ioulia Tseti
Original Assignee
Ioulia Tseti
Uni Pharma Kleon Tsetis Pharmaceutical Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ioulia Tseti, Uni Pharma Kleon Tsetis Pharmaceutical Lab filed Critical Ioulia Tseti
Publication of SMT201300038B publication Critical patent/SMT201300038B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SM201300038T 2010-05-19 2013-04-03 Formulazione di paracetamolo iniettabile stabile epronto per l'uso SMT201300038B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10005258A EP2389923B1 (en) 2010-05-19 2010-05-19 Stable ready to use injectable paracetamol formulation
PCT/EP2011/002482 WO2011144335A1 (en) 2010-05-19 2011-05-18 Stable ready to use injectable paracetamol formulation

Publications (1)

Publication Number Publication Date
SMT201300038B true SMT201300038B (it) 2013-07-09

Family

ID=42338244

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201300038T SMT201300038B (it) 2010-05-19 2013-04-03 Formulazione di paracetamolo iniettabile stabile epronto per l'uso

Country Status (21)

Country Link
US (1) US8877817B2 (it)
EP (1) EP2389923B1 (it)
CN (1) CN102985069B (it)
AP (1) AP3151A (it)
BR (1) BR112012029212A2 (it)
CA (1) CA2799666C (it)
CY (1) CY1113999T1 (it)
DK (1) DK2389923T3 (it)
ES (1) ES2403121T3 (it)
HR (1) HRP20130184T1 (it)
MA (1) MA34314B1 (it)
MY (1) MY160458A (it)
PL (1) PL2389923T3 (it)
PT (1) PT2389923E (it)
RU (1) RU2519764C1 (it)
SI (1) SI2389923T1 (it)
SM (1) SMT201300038B (it)
TN (1) TN2012000516A1 (it)
UA (1) UA104381C2 (it)
WO (1) WO2011144335A1 (it)
ZA (1) ZA201208605B (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA201300398B (en) * 2012-11-27 2013-09-25 Genfarma Laboratories S L Injectable liquid formulation of the combination of tramadol and paracetamol
WO2016008546A1 (en) * 2014-07-18 2016-01-21 Everbright Pharmaceuticals S.A.R.L. Aqueous formulation comprising paracetamol and ibuprofen
CN105797166A (zh) * 2016-03-30 2016-07-27 吉林长白山药业集团股份有限公司 用羟丙基环糊精包合对乙酰氨基酚制成液体制剂的方法
WO2018192664A1 (en) 2017-04-20 2018-10-25 Hyloris Developments Sa METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF
WO2019180072A1 (en) 2018-03-22 2019-09-26 Bayer Pharma Aktiengesellschaft Parenteral pharmaceutical composition comprising neladenoson bialanate
US20230165928A1 (en) * 2020-04-30 2023-06-01 Blue Sky Innovation, Llc Compositions and methods comprising stable reduced glutathione
GR1010637B (el) * 2023-01-13 2024-02-15 Ιουλια Κλεωνος Τσετη Σταθερο υδατικο διαλυμα παρακεταμολης για χρηση σε ενδοφλεβια εγχυση
KR20260020463A (ko) 2023-06-02 2026-02-11 이울리아 츠에티 이부프로펜을 포함하는 약학 조성물
GR1010809B (el) * 2023-09-13 2024-10-25 Ιουλια Τσετη Υδατικο διαλυμα ιβουπροφαινης παρακεταμολης για χρηση σε ενδοφλεβια χορηγηση

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH648371A5 (de) 1982-01-29 1985-03-15 Fischer Ag Georg Anschlusseinrichtung fuer armaturen.
US4727064A (en) 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
FR2751875B1 (fr) 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
JP2001233787A (ja) * 2000-02-04 2001-08-28 Patents Exploitation Co Bv 小・中サイズのペプチド含有薬学的組成物
US20040045546A1 (en) * 2002-09-05 2004-03-11 Peirce Management, Llc Pharmaceutical delivery system for oral inhalation through nebulization consisting of inert substrate impregnated with substance (S) to be solubilized or suspended prior to use
FR2851164B1 (fr) * 2003-02-14 2005-04-22 Xuan Tho Nguyen Formulation liquide injectable de paracetamol
CA2705733C (en) * 2007-11-13 2015-02-03 Cadence Pharmaceuticals Reduced dose intravenous acetaminophen
US20110015273A1 (en) * 2008-01-17 2011-01-20 Rajnarayana Kandhagatla Stable pharmaceutical aqueous compositions
US20090246276A1 (en) * 2008-01-28 2009-10-01 Graham Jackson Pharmaceutical Compositions
EP2253323B1 (en) * 2008-02-29 2019-04-10 Meiji Co., Ltd. Anti-allergic agent

Also Published As

Publication number Publication date
MA34314B1 (fr) 2013-06-01
EP2389923A1 (en) 2011-11-30
US8877817B2 (en) 2014-11-04
AP3151A (en) 2015-03-31
RU2519764C1 (ru) 2014-06-20
DK2389923T3 (da) 2013-03-18
CA2799666C (en) 2016-02-16
TN2012000516A1 (en) 2014-04-01
ES2403121T3 (es) 2013-05-14
CA2799666A1 (en) 2011-11-24
MY160458A (en) 2017-03-15
BR112012029212A2 (pt) 2020-09-29
PT2389923E (pt) 2013-03-28
SI2389923T1 (sl) 2013-06-28
AP2012006597A0 (en) 2012-12-31
PL2389923T3 (pl) 2013-06-28
HRP20130184T1 (hr) 2013-05-31
CN102985069B (zh) 2014-11-26
HK1182315A1 (en) 2013-11-29
WO2011144335A1 (en) 2011-11-24
UA104381C2 (uk) 2014-01-27
WO2011144335A8 (en) 2012-12-06
EP2389923B1 (en) 2013-01-30
CN102985069A (zh) 2013-03-20
US20130210922A1 (en) 2013-08-15
ZA201208605B (en) 2013-09-25
CY1113999T1 (el) 2016-07-27

Similar Documents

Publication Publication Date Title
BR112012013148A2 (pt) formulação farmacêutica e uso
HRP20190137T1 (hr) Stabilne formulacije polipeptida i njihova uporaba
BR112013011448A2 (pt) composto, composição farnmacêutica, e, uso do composto
SMT201500210B (it) Composizioni applicazioni di gel rimovibili per unghie e metodi per il loro uso
BR112013010988A2 (pt) composição fluída e uso
SMT201400181B (it) Composizioni per vasocostrizione e metodi d'uso
SMT201400055B (it) Composti di tioacetato, composizioni e metodi d'uso
BRPI0822104A2 (pt) Composições antimicrobianas e métodos para o uso das mesmas
BR112014014547A2 (pt) compostos antagonistas de e-selectina, composições e métodos de uso
BR112013023681A2 (pt) compostos de álcool propargílico 6,5-heterocíclico e uso dos mesmos
BR112013023174A2 (pt) "compostos derivados de triterpenoide de c4-monometila, composição farmacêutica compreendendo os referidos compostos e uso dos mesmos"
BR112013008259A2 (pt) composto, composição farmacêutica, e, uso de um composto
SMT201900656T1 (it) Formulazioni di ketorolac pronte all'uso
BR112012012969A2 (pt) '' formulação farmacêutica líquida e uso de um antioxidante''
BRPI0909954A2 (pt) "diazacarbazóis e métodos de uso"
BR112013006016A2 (pt) compostos de azabenzotiazol, composições e métodos de uso
IT1398930B1 (it) Formulazioni farmaceutiche bistrato contenenti agonisti ed antagonisti oppioidi.
BRPI1007494A2 (pt) composto e uso do mesmo
BR112012001797A2 (pt) composto bicíclico e uso do mesmo para propósitos médicos
PT3812360T (pt) Compostos de monoclorotrifluoropropeno e composições e métodos utilizando os mesmos
BR112013003530A2 (pt) ''produto farmacêutico, kit, uso e preparações''
CO6781486A2 (es) Compuestos y su uso
ZA201208605B (en) Stable ready to use injectable paracetamol formulation
BR112012019473A2 (pt) compostos composição farmacêutica combinação de um composto uso de um composto e dispositivo
BR112012031861A2 (pt) uso de 5a-androstano (alquil)-3b, 5, 6b-triol